What is IRadimed?
IRadimed is a mri-compatible medical devices company serving enterprise, commercial, consumer, healthcare, financial, real estate, or regulated-market customers.
- Category
- MRI-compatible medical devices
- Headquarters
- Winter Springs, FL
- Founded
- See official company history
- Employees
- See latest annual report and company filings
- Total funding
- Public company
- Status
- Public company; Nasdaq: IRMD
What is IRadimed?
IRadimed is a mri-compatible medical devices company headquartered in Winter Springs, FL. Its public-company profile is most useful for account planning when combined with current filings, investor materials, job posts, product launches, and partner announcements.
IRadimed is a mri-compatible medical devices company headquartered in Winter Springs, FL. Its public-company profile is most useful for account planning when combined with current filings, investor materials, job posts, product launches, and partner announcements.
For sellers, IRadimed should be mapped as a scaled public-company account. The best timing signals are earnings commentary, capital spending, hiring clusters, product launches, acquisitions, facility investments, and leadership changes.
What does IRadimed offer?
IRadimed's profile centers on MRI infusion pumps, MRI patient monitors, Medical devices, Hospital equipment.
- MRI infusion pumps· MRI-compatible medical devices
- MRI patient monitors· MRI-compatible medical devices
- Medical devices· MRI-compatible medical devices
- Hospital equipment· MRI-compatible medical devices
- Clinical monitoring· MRI-compatible medical devices
- Consumables· MRI-compatible medical devices
How does IRadimed make money?
IRadimed makes money through commercial activity tied to mri-compatible medical devices.
IRadimed monetizes through the model common to mri-compatible medical devices: product sales, recurring services, contracts, leases, subscriptions, transaction volume, servicing, investment management, or usage depending on the operating unit.
Sales angles should connect to measurable priorities such as margin, growth, occupancy, compliance, retention, automation, risk reduction, data quality, customer experience, or field productivity.
Who leads IRadimed?
IRadimed's named executives should be verified on the official leadership or investor-relations page before outreach.
- IRadimed executive leadershipExecutive leadership teamCurrent as of June 2026Use the official leadership, governance, or investor-relations page for current named executives before outreach.
- IRadimed finance leadershipFinance / CFO organizationCurrent as of June 2026Often owns investor communication, procurement governance, capital allocation, and budget discipline.
- IRadimed operations or technology leadershipOperations, product, technology, security, or commercial leadershipCurrent as of June 2026Likely stakeholder group for software, infrastructure, data, workflow, and operating-improvement purchases.
How do you contact IRadimed's leadership?
IRadimed should be contacted through official investor, media, partner, support, or sales routes unless a named executive publishes a direct address.
contact via https://www.iradimed.com- IRadimed investor relationsInvestor relations / corporate contactcontact via https://www.iradimed.com
How is IRadimed funded?
IRadimed's current status is Public company; Nasdaq: IRMD.
IRadimed's capital profile is best understood through its current public-company status: Public company; Nasdaq: IRMD. For public companies, financing and budget signals are usually found in annual reports, quarterly results, debt disclosures, buybacks, acquisitions, capital expenditure plans, and management commentary rather than venture funding rounds.
Before outreach, verify the latest status on the company's investor-relations page and current exchange filings.
How did IRadimed get here?
IRadimed's history should be read through founding, scale-up, public-market ownership, and current product or market focus.
- FoundingIRadimed is foundedThe company begins building in mri-compatible medical devices.
- Scale-upCommercial footprint expandsIRadimed broadens its product, customer, distribution, or geographic reach.
- Public marketsPublic company; Nasdaq: IRMDPublic-company ownership shapes reporting, procurement, and operating priorities.
- 2025Scaled operating profileThe company operates with specialized teams and repeatable buying centers.
- June 2026Current profile refreshedProfile generated from official domain, public-company status, and source references.
Who are IRadimed's competitors?
IRadimed competes with larger incumbents and focused specialists in mri-compatible medical devices.
IRadimed — frequently asked questions
